← Eichor
Study identifier: NCT06121219 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Visual Retraining After Stroke

Condition: Vision Loss Partial · Vision; Loss, Both Eyes · Hemianopia Homonymous  ·  Sponsor: University of Rochester

PhaseNA
Planned participants100
Who can joinAll sexes, 21 Years to 80 Years
Healthy volunteersYes

About this study

This project is intended to collect data using standard clinical tests and psychophysics to quantify the effect of visual cortical damage on the structure of the residual visual system, visual perception, spatial awareness, and brain function. The investigators will also assess the effect of intensive visual retraining on the residual visual system, processing of visual information and the use of such information in real-world situations following damage. This research is intended to improve our understanding of the consequences of permanent visual system damage in humans, of methods that can be used to reverse visual loss, and of brain mechanisms by which visual recovery is achieved.

This description comes directly from the study's public registry record.

Talk to the study team

Evan Burr  ·  585-275-5234  ·  Evan_Burr@urmc.rochester.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Rochester Medical CenterRochester, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06121219